Nutrients,
Journal Year:
2024,
Volume and Issue:
17(1), P. 54 - 54
Published: Dec. 27, 2024
Background:
Fructose
(50%
of
sucrose/sugar)
is
one
component
free-sugars
and
metabolized
to
uric
acid,
which
a
known
risk
factor
for
gout
metabolic
syndrome.
Pacific
peoples
in
New
Zealand
experience
higher
prevalence
gout,
type
2
diabetes,
overweight/obesity
than
other
ethnic
groups.
Interestingly,
despite
having
similar
body
mass
index
(BMI),
they
tend
have
proportion
appendicular
skeletal
muscle
(ASMM)
less
fat
Given
this
context,
study
aimed
evaluate
the
associations
between
serum
acid
(SUA),
free-sugar
intake,
ASMM.
Methods:
In
nested
sub-study
from
Islands
Families
birth-cohort
study,
101
boys
99
girls
(all
aged
14
15
years)
self-reported
how
often
had
consumed
foods
containing
sugar
past
month.
Anthropometry,
fatness,
ASMM
by
dual-energy
X-ray
absorptiometry
factors,
including
SUA
were
measured.
Results:
Overall,
43%
57%
‘sugary
drinks’
twice
or
more
day.
When
analyzed
group,
was
positively
related
both
(r
=
0.593,
p
<
0.0001).
The
effect
intake
on
0.176,
0.013)
reduced
when
considered
relationships.
Conclusions:
This
shows
high
levels
adolescents,
with
positive
association
genders.
Sugary
drink
associated
girls.
High
people
an
increased
raised
make
it
important
work
communities
reduce
added
adopt
integrated,
family-based,
culturally
centered,
life-course
approaches
prevent
chronic
diseases,
gout.
Cell Communication and Signaling,
Journal Year:
2025,
Volume and Issue:
23(1)
Published: Jan. 3, 2025
Oxidative
stress
and
neuroinflammation
are
recognized
as
key
factors
in
the
development
of
neurodegenerative
diseases,
yet
effective
interventions
biomarkers
to
address
oxidative
these
conditions
limited.
Uric
acid
(UA),
traditionally
associated
with
gout,
is
now
gaining
prominence
a
potential
target
diseases.
Soluble
UA
stands
out
one
most
vital
antioxidant
compounds
produced
by
human
body,
accounting
for
up
55%
extracellular
capacity
neutralize
free
radicals.
While
there
increasing
evidence
supporting
neuroprotective
properties
Parkinson's
disease
Alzheimer's
disease,
gaps
knowledge
still
exist
regarding
underlying
mechanisms
how
effectively
translate
benefits
into
clinical
practice.
Moreover,
current
elevation
therapy
exhibits
unstable
properties,
individual
variability,
even
adverse
effects,
limiting
its
applications.
This
review
consolidates
recent
advancements
understanding
exerts
effects
on
diseases
emphasizes
dual
roles
managing
neuroinflammation.
Additionally,
elucidates
through
which
confers
neuroprotection.
Based
this,
underscores
significance
biomarker
aims
provide
comprehensive
therapeutic
target,
while
also
addressing
possible
challenges
implementation.
JACS Au,
Journal Year:
2025,
Volume and Issue:
5(3), P. 1308 - 1319
Published: Feb. 23, 2025
The
urate
transporter
1
(URAT1)
is
the
primary
in
kidney
responsible
for
reabsorption
and,
therefore,
crucial
homeostasis.
Hyperuricemia
causes
common
human
disease
gout
and
other
pathological
consequences.
Inhibition
of
through
URAT1
has
been
shown
as
a
promising
strategy
alleviating
hyperuricemia,
clinical
preclinical
drug
candidates
targeting
are
emerging.
However,
how
small
molecules
inhibit
remains
undefined,
lack
accurate
complex
structures
hinders
development
better
therapeutics.
Here,
we
present
cryoelectron
microscopy
humanized
rat
bound
with
benzbromarone,
lingdolinurad,
verinurad,
elucidating
structural
basis
recognition
inhibition.
three
reside
central
cavity
different
binding
modes,
locking
an
inward-facing
conformation.
This
study
provides
mechanistic
insights
into
modulation
sheds
light
on
rational
design
potential
URAT1-specific
therapeutics
treating
hyperuricemia.
Frontiers in Immunology,
Journal Year:
2025,
Volume and Issue:
16
Published: Feb. 28, 2025
Introduction
Pyroptosis
is
an
important
inflammatory
form
of
cell
death
and
Mycobacterium
tuberculosis
(
M.tb
)
chronic
infection
triggers
excessive
pyroptosis
macrophages.
Our
previous
research
has
confirmed
that
a
small
compound
pyrvinium
pamoate
(PP)
could
inhibit
pathological
changes
mycobacterial
burden
in
-infected
mice,
but
the
potential
mechanism
PP
for
inhibiting
-induced
inflammation
remains
unexplored.
Methods
The
effects
on
NLRP3-ASC-Casp1
inflammasome
assembly
activation,
gasdermin
D
(GSDMD)
mediated
cytokines
expression
were
assessed
human
THP-1-derived
macrophages
after
H37Rv/H37Ra/
Salmonella
typhimurium
S.
or
LPS
treatment
by
Transcriptome
sequencing,
RT-qPCR,
Co-immunoprecipitation
Western
Blot
(WB)
analysis.
lactate
dehydrogenase
(LDH)
release
assay
was
used
to
evaluate
CC50
THP-1
cells.
Results
We
found
/
significantly
activate
GSDMD-mediated
(IL-1β
IL-18)
macrophages,
whereas
suppress
these
dose
dependent
manner.
Regarding
PP-inhibition
mechanism,
we
further
this
inhibitory
activity
through
PP-targeting
casein
kinase
1A1
(CK1α)–β-catenin–NF-κB
pathway
CK1α–NRF2–mitochondrial
oxidative
phosphorylation
(OXPHOS)
pathway.
In
addition,
CK1α
specific
inhibitor
D4476
siRNA
reverse
bacteria-induced
responses
Conclusions
This
study
reveals
previously
unreported
can
NLRP3
GSDMD–IL-1β
via
targeting
suppressing
CK1α–β-catenin–NF-κB
OXPHOS
pathways,
suggesting
holds
great
promise
as
host
directed
therapy
(HDT)
drug
mycobacterial-induced
response.
Diabetes Metabolic Syndrome and Obesity,
Journal Year:
2025,
Volume and Issue:
Volume 18, P. 785 - 793
Published: March 1, 2025
To
assess
the
plasma
concentrations
of
novel
hepatokine
fetuin-B
in
individuals
with
type
2
diabetes
or
without
diabetic
peripheral
neuropathy
(DPN),
and
to
evaluate
relationship
among
levels,
nervous
function,
metabolic
parameters.
A
total
333
participants
were
recruited
divided
into
three
groups:
DPN,
painful
DPN
(pDPN),
non-DPN.
Metabolic
parameters,
neuropathy-associated
indices,
general
biochemical
parameters
also
measured.
Compared
non-DPN
group,
including
age,
SBP,
BUN,
Cr,
ALT,
significantly
higher
pDPN
groups,
FPG,
HbA1c,
TC,
TG,
LDL,
UA
levels
group.
The
symptom
score
(NSS),
disability
(NDS),
Douleur
Neuropathique
en
4
Questions
(DN4)
highest
followed
by
lowest
Moreover,
fetuin
B
showed
same
trends
as
indices.
Additionally,
oxidative
stress
markers
a
decrease
antioxidant
capacity
(TAC)
an
increase
malondialdehyde
(MDA)
across
all
most
pronounced
changes
observed
patients.
Bivariate
correlation
analysis
that
positively
correlated
NSS,
NDS,
DN4,
MDA
negatively
associated
TAC
after
adjusting
for
age
sex.
Furthermore,
nerve
conduction
velocity,
MLT,
MRT,
SRS,
SLT,
decreasing
tertiles
levels.
current
study
suggests
circulating
may
be
progression
highlights
effects
hepatokine-mediated
liver-to-peripheral
system
crosstalk
DPN.
Gout Urate and Crystal Deposition Disease,
Journal Year:
2025,
Volume and Issue:
3(2), P. 7 - 7
Published: April 10, 2025
Monosodium
urate,
calcium
pyrophosphate,
and
basic
phosphate
crystals
are
the
most
common
types
of
found
in
joints.
Each
type
crystal
has
been
associated
with
onset
different
joint
diseases.
However,
mechanisms
identified
for
one
often
generalized
to
others;
thus,
overlooking
specific
distinct
molecular
cellular
responses
activated
by
each
crystal.
This
review
describes
similarities
differences
main
molecules
underlying
diseases
three
crystals.
Specifically,
current
knowledge
on
properties
formation,
induction
resolution
inflammation,
involved
pain
processing
senescence,
role
mitochondria
genomic
instability
elucidated.
A
more
complete
detailed
study
induced
is
necessary
advance
our
understanding
pathogenesis
help
identify
innovative
opportunities
prevention
treatment
deposition
disease.